Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from ONO Pharmaceutical Co ( (JP:4528) ).
ONO Pharmaceutical Co., Ltd. reported its consolidated financial results for the first quarter of the fiscal year ending March 31, 2026. The company experienced an 8.4% increase in revenue compared to the same period last year, despite a decline in operating profit and profit before tax. The financial forecast for the fiscal year 2025 anticipates a slight revenue increase and significant growth in operating profit, highlighting the company’s strategic focus on improving profitability.
The most recent analyst rating on (JP:4528) stock is a Hold with a Yen1800.00 price target. To see the full list of analyst forecasts on ONO Pharmaceutical Co stock, see the JP:4528 Stock Forecast page.
More about ONO Pharmaceutical Co
ONO Pharmaceutical Co., Ltd. is a company listed on the Tokyo Stock Exchange, operating in the pharmaceutical industry. The company focuses on the development and sale of pharmaceutical products.
Average Trading Volume: 2,383,645
Technical Sentiment Signal: Sell
Current Market Cap: Yen779.8B
See more data about 4528 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money